High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosis

Publication Type:

Journal Article

Source:

J Hepatol, Volume 69, Issue 2, p.293-300 (2018)
Top